Int. J. Mol. Sci. 2013, 14(10), 20597-20613; doi:10.3390/ijms141020597
Review

The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease

1 Department of Internal Medicine, University of Iowa, Iowa City, IA 52242, USA 2 Veterans Affairs Medical Center, Iowa City, IA 52242, USA
* Author to whom correspondence should be addressed.
Received: 24 July 2013; in revised form: 20 September 2013 / Accepted: 8 October 2013 / Published: 15 October 2013
(This article belongs to the Special Issue Oxidative Stress in Cardiovascular Disease)
PDF Full-text Download PDF Full-Text [635 KB, uploaded 15 October 2013 13:38 CEST]
Abstract: The epidermal growth factor receptor (EGFR) family and its ligands serve as a switchboard for the regulation of multiple cellular processes. While it is clear that EGFR activity is essential for normal cardiac development, its function in the vasculature and its role in cardiovascular disease are only beginning to be elucidated. In the blood vessel, endothelial cells and smooth muscle cells are both a source and a target of EGF-like ligands. Activation of EGFR has been implicated in blood pressure regulation, endothelial dysfunction, neointimal hyperplasia, atherogenesis, and cardiac remodeling. Furthermore, increased circulating EGF-like ligands may mediate accelerated vascular disease associated with chronic inflammation. Although EGFR inhibitors are currently being used clinically for the treatment of cancer, additional studies are necessary to determine whether abrogation of EGFR signaling is a potential strategy for the treatment of cardiovascular disease.
Keywords: EGFR; EGF-like ligands; vascular disease; atherosclerosis; cardiac remodeling

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Makki, N.; Thiel, K.W.; Miller, F.J., Jr. The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease. Int. J. Mol. Sci. 2013, 14, 20597-20613.

AMA Style

Makki N, Thiel KW, Miller FJ, Jr. The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease. International Journal of Molecular Sciences. 2013; 14(10):20597-20613.

Chicago/Turabian Style

Makki, Nader; Thiel, Kristina W.; Miller, Francis J., Jr. 2013. "The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease." Int. J. Mol. Sci. 14, no. 10: 20597-20613.

Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert